- Home
- BIO vs CIB Comparison
BIO vs CIB Comparison
Compare BIO & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- CIB
- Stock Information
- Founded
- BIO 1952
- CIB 1945
- Country
- BIO United States
- CIB Colombia
- Employees
- BIO N/A
- CIB N/A
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- CIB Commercial Banks
- Sector
- BIO Industrials
- CIB Finance
- Exchange
- BIO Nasdaq
- CIB Nasdaq
- Market Cap
- BIO 9.5B
- CIB 7.6B
- IPO Year
- BIO N/A
- CIB 1995
- Fundamental
- Price
- BIO $343.61
- CIB $33.31
- Analyst Decision
- BIO Strong Buy
- CIB Sell
- Analyst Count
- BIO 4
- CIB 4
- Target Price
- BIO $381.50
- CIB $32.40
- AVG Volume (30 Days)
- BIO 182.3K
- CIB 293.7K
- Earning Date
- BIO 10-30-2024
- CIB 11-07-2024
- Dividend Yield
- BIO N/A
- CIB 10.16%
- EPS Growth
- BIO N/A
- CIB N/A
- EPS
- BIO N/A
- CIB 1.52
- Revenue
- BIO $2,562,604,000.00
- CIB $5,106,679,588.00
- Revenue This Year
- BIO N/A
- CIB N/A
- Revenue Next Year
- BIO $4.49
- CIB $2.59
- P/E Ratio
- BIO N/A
- CIB $5.66
- Revenue Growth
- BIO N/A
- CIB 2.14
- 52 Week Low
- BIO $261.59
- CIB $24.90
- 52 Week High
- BIO $364.24
- CIB $37.85
- Technical
- Relative Strength Index (RSI)
- BIO 55.67
- CIB 62.32
- Support Level
- BIO $338.84
- CIB $32.06
- Resistance Level
- BIO $350.53
- CIB $33.03
- Average True Range (ATR)
- BIO 7.98
- CIB 0.64
- MACD
- BIO 0.24
- CIB 0.20
- Stochastic Oscillator
- BIO 67.74
- CIB 96.73
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About CIB BanColombia S.A.
BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala.